Kojic acid

What has happened over the last six months? In this “Ingredients” section of the summer Round-ups: a summary of the SCCS Opinions and ECHA’s work. On the SCCS side, a number of final Opinions are already being incorporated into a draft Regulation (Thimersal, Cannabidiol…), whilst work continues on certain fragrance ingredients (Heliotropine, Acetophenone, Cyclamen aldehyde, Cuminaldehyde, p-Cymene…) and on exposure to salicylic acid.

The 28 substances included in CoRAP 2025-2027, which are suspected of posing a risk to human health or the environment, will be assessed by the competent authorities of eight Member States. This plan includes 13 new entries and 18 already present in previous CoRAPs. Of these 18, 12 have had their evaluations postponed, mainly, explains ECHA, pending new data that has been requested. Eight substances are due to be evaluated in 2025, 15 in 2026 and 5 in 2027.

The UK’s SAG-CS has recently published opinions on the use of Butylated Hydroxytoluene (BHT) and Kojic Acid in cosmetic products. These opinions partially differ from those of the EU’s SCCS. In the UK, the Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) is acknowledged as the counterpart of EU's Scientific Committee on Consumer Safety (SCCS).